Blog icon

PainChek® is a smartphone-based medical device used to assess pain in non-verbal people. It is the world’s first pain assessment tool with regulatory clearance in Australia and Europe.

The challenge

Unrecognised and undertreated chronic pain

Painaustralia reports that chronic pain affects 20 per cent of Australians, and one in three people over 65. Additionally, 80 per cent of residents in aged care homes experience pain. Pain often goes unrecognised and under-treated in people with cognitive and communication difficulties such as those living with dementia. The burden of this condition extends across the society.

Our response

Pain assessment

PainChek® is a fast and easy-to-use pain assessment app that provides carers with the ability to identify the presence of pain, quantify its intensity level, and monitor the impact of treatment to optimise overall care.

The results

Significant impact for dementia patients

PainChek is in the nascent stages of operation but well-placed to generate societal and economic benefits for Australia. It is projected to have significant benefits for dementia patients.

The present value of the total health benefits of PainChek® for Australians living with dementia (moderate to severe pain) between 2018–27 is estimated to be $1.4 billion (in 2019 dollars at a seven per cent real discount rate). The benefit‑cost ratio is estimated as 1,446.

Report Links

Related to this page

Contact us

Find out how we can help you and your business. Get in touch using the form below and our experts will get in contact soon!

First name must be filled in

Surname must be filled in

I am representing *

Please choose an option

Please provide a subject for the enquriy

0 / 100

We'll need to know what you want to contact us about so we can give you an answer

0 / 1900

You shouldn't be able to see this field. Please try again and leave the field blank.